Inactivation of gram-positive bacteria

John Galloway Anderson; Michelle Maclean; Gerald Alexander Woolsey; Scott John MacGregor

Inactivation of gram-positive bacteria

John Galloway Anderson (Inventor), Michelle Maclean (Inventor), Gerald Alexander Woolsey (Inventor), Scott John MacGregor (Inventor)

Electronic And Electrical Engineering

Research output: Patent

Abstract

A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.

Original language	English
Patent number	US11730838B2
Priority date	17/02/21
Filing date	17/02/21
Publication status	Published - 22 Aug 2023

Keywords

Gram-positive bacteria
visible light

Access to Document

https://patents.google.com/patent/US11730838B2/en

Cite this

@misc{39528084e230463cbb75dad85c1ada85,

title = "Inactivation of gram-positive bacteria",

abstract = "A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.",

keywords = "Gram-positive bacteria, visible light",

author = "Anderson, {John Galloway} and Michelle Maclean and Woolsey, {Gerald Alexander} and MacGregor, {Scott John}",

year = "2023",

month = aug,

day = "22",

language = "English",

type = "Patent",

note = " US11730838B2",

}

TY - PAT

T1 - Inactivation of gram-positive bacteria

AU - Anderson, John Galloway

AU - Maclean, Michelle

AU - Woolsey, Gerald Alexander

AU - MacGregor, Scott John

PY - 2023/8/22

Y1 - 2023/8/22

N2 - A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.

AB - A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative Staphylococcus (CONS), Streptococcus, Enterococcus and Clostridium species, comprising exposure to visible light, and in particular light within the wavelength range 400-500 nm.

KW - Gram-positive bacteria

KW - visible light

M3 - Patent

M1 - US11730838B2

Y2 - 2021/02/17

ER -

Inactivation of gram-positive bacteria

Abstract

Keywords

Access to Document

Fingerprint

Cite this